NCT01332903View on ClinicalTrials.gov

Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Healthy
Interventions
DRUG

[14C] AZD5069

Single 120 mg oral dose administered on Day 1

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01332903 - Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069 | Biotech Hunter | Biotech Hunter